Literature DB >> 9832491

Mechanisms of vasorelaxation induced by troglitazone, a novel antidiabetic drug, in the porcine coronary artery.

J Kawasaki1, K Hirano, J Nishimura, M Fujishima, H Kanaide.   

Abstract

BACKGROUND: Troglitazone (TRO), a novel antidiabetic drug, has been reported to decrease blood pressure and relax vascular strips. The mechanism of relaxation induced by TRO was determined in terms of Ca2+ signaling in smooth muscle cells. METHODS AND
RESULTS: Front-surface fluorometry and fura 2-loaded medial strips of porcine coronary artery were used to examine the effects of TRO on cytosolic Ca2+ concentrations ([Ca2+]i) and contractions. The sustained contraction induced by 100 nmol/L U46619 was similar to that induced by 60 mmol/L K+ depolarization (60K+). TRO concentration dependently decreased [Ca2+]i and the force of these contractions. The concentration of TRO required to induce 50% inhibition of U46619-induced force (2.9 micromol/L) was significantly lower than that required in the case of 60K+-induced force (7.3 micromol/L). Replacing extracellular Ca2+ with Mn2+ gradually quenched fluorescence at 360 nm excitation. This decline was accelerated by 100 nmol/L U46619 and 30K+ to a similar extent, indicating a similar activation of Ca2+ influx. TRO completely inhibited U46619-activated influx but partly inhibited depolarization-activated influx. Cumulative applications of extracellular Ca2+ during stimulations with U46619 or 118K+ induced stepwise increases in [Ca2+]i and force. TRO shifted the [Ca2+]i-force relation to the right during both stimulations.
CONCLUSIONS: TRO relaxes coronary artery by decreasing [Ca2+]i and Ca2+ sensitivity of contractile apparatus. Inhibition of Ca2+ influx was important in decreasing [Ca2+]i. TRO more effectively inhibits receptor-operated Ca2+ influx than voltage-operated Ca2+ channels.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9832491     DOI: 10.1161/01.cir.98.22.2446

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  5 in total

Review 1.  Pleiotropic effects of thiazolidinediones: taking a look beyond antidiabetic activity.

Authors:  S Giannini; M Serio; A Galli
Journal:  J Endocrinol Invest       Date:  2004-11       Impact factor: 4.256

2.  Ca(2+) influx in the endothelial cells is required for the bradykinin-induced endothelium-dependent contraction in the porcine interlobar renal artery.

Authors:  E Ihara; D N Derkach; K Hirano; J Nishimura; H Nawata; H Kanaide
Journal:  J Physiol       Date:  2001-08-01       Impact factor: 5.182

3.  Effect of thiazolidinedione on the proliferation of bovine retinal endothelial cells stimulated by vascular endothelial cell growth factor.

Authors:  Goro Hiroishi; Toshinori Murata; Tatsuro Ishibashi
Journal:  Jpn J Ophthalmol       Date:  2007-02-09       Impact factor: 2.447

Review 4.  Effects of thiazolidinediones on blood pressure.

Authors:  Thomas D Giles; Gary E Sander
Journal:  Curr Hypertens Rep       Date:  2007-08       Impact factor: 5.369

5.  The role of peroxisome proliferator-activated receptor gamma in blood pressure regulation.

Authors:  Milton Hamblin; Lin Chang; Jifeng Zhang; Y Eugene Chen
Journal:  Curr Hypertens Rep       Date:  2009-08       Impact factor: 4.592

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.